ロード中...

Polyvalent pneumococcal polysaccharide vaccines

A 14-valent pneumococcal vaccine has recently been licensed for general use after extensive testing in human subjects. Antibody production was satisfactory in 92% of individuals and a highly significant (76-92%) reduction was found in the rates for pneumococcal pneumonias caused by the capsular type...

詳細記述

保存先:
書誌詳細
主要な著者: Hilleman, M. R., McLean, A. A., Vella, P. P., Weibel, R. E., Woodhour, A. F.
フォーマット: Artigo
言語:Inglês
出版事項: 1978
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2395578/
https://ncbi.nlm.nih.gov/pubmed/28857
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!